Relationship between use of antidepressants and risk of fractures: a meta-analysis (Q34277620)

1 August 2017

0 references

Relationship between use of antidepressants and risk of fractures: a meta-analysis (English)

1 reference

1 August 2017

0 references

1 reference

V Rabenda

1 reference

1 August 2017

D Nicolet

1 reference

1 August 2017

C Beaudart

1 reference

1 August 2017

O Bruyère

1 reference

1 August 2017

J-Y Reginster

1 reference

1 August 2017

language of work or name

English

0 references

publication date

26 May 2012

1 reference

Osteoporosis International

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

121-137

1 reference

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Psychotropic Drugs and Falls in the Elderly People: Updated Literature Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The adverse skeletal effects of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

SSRIs, bone mineral density, and risk of fractures--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Psychotropic medications and the risk of fracture: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The file drawer problem and tolerance for null results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Psychotropic drug use and the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Current use of thiazide diuretics and prevention of femur fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Elderly patients, use of antidepressants, and hip fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Zolpidem use and hip fractures in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Epidemiology of lower limb fractures in general practice in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Outpatient medications and hip fractures in the US: a national veterans study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Risk of hip/femur fractures in patients using antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Fracture risk from psychotropic medications: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of anti-depressants and the risk of fracture of the hip or femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Central nervous system active medications and risk for fractures in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Predictors of Non-Spine Fracture in Elderly Men: The MrOS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Effect of selective serotonin reuptake inhibitors on the risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Risk factors associated with the occurrence of fractures in U.S. nursing homes: resident and facility characteristics and prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depressive symptoms, bone loss, and fractures in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Psychotropic drugs and the risk of fractures in old age: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Binge drinking: all too prevalent and hazardous

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of antidepressant medications and risk of fracture in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Antidepressants and Fracture Risk in Older Adults: A Comparative Safety Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The two faces of serotonin in bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Low bone mass in premenopausal women with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depression, antidepressants, and bone mineral density in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Bone mineral density in women with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The association of bone mineral density and depression in an older population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depression and hip fracture risk: the NHANES I epidemiologic follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Bone mineral density and depression: a community study in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Bone mineral density in premenopausal women with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Psychological status and depression in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Bone mineral density and disorders of mineral metabolism in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Diabetes mellitus, bone mineral density, and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

A review of the relationship between depression and diabetes in adults: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Use of oral corticosteroids and risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depressive Symptoms and Rates of Bone Loss at the Hip in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Depressive Symptoms and Bone Mineral Density in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2015-9

Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women

21 January 2018

1 reference

12 December 2020

Special issues in the management of depression in older patients

1 reference

12 December 2020

Psychotropic drugs and injuries among the elderly: a review

1 reference

12 December 2020

Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture

1 reference

12 December 2020

Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.

1 reference

12 December 2020

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture

1 reference

12 December 2020

Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.

1 reference

12 December 2020

Recent developments in antidepressant therapy in special populations.

1 reference

12 December 2020

Reduced relative risk of fractures among users of lithium

1 reference

12 December 2020

Antidepressants and the risk of falls among nursing home residents

1 reference

12 December 2020

Risk factors for hip fractures occurring in the hospital

1 reference

12 December 2020

Psychotropics, thiazide diuretics and hip fractures in the elderly.

1 reference

12 December 2020

Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly

1 reference

12 December 2020

Antidepressants and falls among elderly people in long-term care

1 reference

12 December 2020

Characteristics of lifetime factors, bone metabolism, and bone mineral density in patients with hip fracture

1 reference

12 December 2020

Drugs and femoral neck fracture: a case-control study

1 reference

12 December 2020

Risk factors for fractures in the elderly

1 reference

12 December 2020

Cyclic antidepressants and the risk of hip fracture

1 reference

12 December 2020

10.1007/S00198-012-2015-9

Identifiers

DOI

1 reference

release_lo6ueyrwubfunp3j2ukjnlxlvm

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lo6ueyrwubfunp3j2ukjnlxlvm

24 November 2022

mapped directly with Wikidata item

1 reference